Fred Turner

Fred Turner is the current CEO at Curative. Fred has also served as CEO at Shield Bio and TL Biolabs Corp. In their role at Shield Bio, they were responsible for ensuring that antibiotic resistance didn't become more deadly than cancer. At TL Biolabs Corp, they oversaw genomic testing for the dairy industry to determine characteristics of animals from birth using high throughput genomics testing technologies.

Fred Turner's educational career began at the Crossley Heath School. Fred then attended the University of Oxford, where they earned a Master of Biochemistry in Biochemistry and Molecular Biology. Finally, they attended Y Combinator, where they received training in business and technology.

Some individuals on their team include Ryan Souders - General Counsel, Mark Willig - Chief Commercial Officer, and Lee Spraggon - Chief Innovation Officer.